A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids

PHASE2CompletedINTERVENTIONAL
Enrollment

173

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2013

Conditions
Renal Transplant
Interventions
DRUG

Belatacept

IV, IV Infusion, 5 mg/kg once every 28 days for one year

DRUG

Cyclosporine A

Tablets, Oral, Trough of 100-250 ng/mL, 2\* daily for one year

DRUG

Tacrolimus

Tablets, Oral, Trough of 5-10 ng/mL, 2\* daily for one year

Trial Locations (44)

1070

Local Institution, Brussels

1155

Local Institution, Buenos Aires

2000

Local Institution, Rosario

2650

Local Institution, Edegem

3050

Local Institution, Parkville

5016

Local Institution, Córdoba

10117

Charite Berlin Mitte, Berlin

14000

Local Institution, Df

14080

Local Institution, Tlalpan, C P

20000

Local Institution, Aguascalientes

46017

Local Institution, Valencia

53226

Medical College Of Wisconsin, Milwaukee

60637

University Of Chicago, Chicago

62448

Local Institution, Cuernavaca

66421

Local Institution, Homburg/saar

70062

Pharmacy, First Call Iv, Kenner

70112

Tulane University Hospital & Clinic, New Orleans

75743

Local Institution, Paris

78240

Local Institution, San Luis Potosí City

85054

Mayo Clinic Hospital, Phoenix

90057

National Institute Of Transplantation, Los Angeles

92123

California Institute Of Renal Research, San Diego

380007

Local Institution, Pāladi

387001

Local Institution, Nadiād

682304

Local Institution, Kochi

94143-0106

Ucsf, San Francisco

27599-7155

University Of North Carolina School Of Medicine, Chapel Hill

C1425APQ

Local Institution, Capital Federal

S3000EPV

Local Institution, Santa Fe

80240-000

Local Institution, Curitiba

21041-030

Local Institution, Bonsucesso

90020-090

Local Institution, Porto Alegre

90035-003

Local Institution, Porto Alegre

01323-900

Local Institution, São Paulo

T6G 2G3

Local Institution, Edmonton

B3H 1V8

Local Institution, Halifax

L8N 4A6

Local Institution, Hamilton

S7M 0Z9

Local Institution, Saskatoon

Cedex 09

Local Institution, Toulouse

85-094

Local Institution, Bydgoszcz

70-111

Local Institution, Szczecin

02-006

Local Institution, Warsaw

08026

Local Institution, Barcelona

08907

Local Institution, Barcelona

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY